BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 33114233)

  • 1. Evaluation of Commercially Available Viral Transport Medium (VTM) for SARS-CoV-2 Inactivation and Use in Point-of-Care (POC) Testing.
    van Bockel D; Munier CML; Turville S; Badman SG; Walker G; Stella AO; Aggarwal A; Yeang M; Condylios A; Kelleher AD; Applegate TL; Vallely A; Whiley D; Rawlinson W; Cunningham P; Kaldor J; Guy R
    Viruses; 2020 Oct; 12(11):. PubMed ID: 33114233
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Large-Scale, In-House Production of Viral Transport Media To Support SARS-CoV-2 PCR Testing in a Multihospital Health Care Network during the COVID-19 Pandemic.
    Smith KP; Cheng A; Chopelas A; DuBois-Coyne S; Mezghani I; Rodriguez S; Talay M; Kirby JE
    J Clin Microbiol; 2020 Jul; 58(8):. PubMed ID: 32404481
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Detection of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Is Comparable in Clinical Samples Preserved in Saline or Viral Transport Medium.
    Radbel J; Jagpal S; Roy J; Brooks A; Tischfield J; Sheldon M; Bixby C; Witt D; Gennaro ML; Horton DB; Barrett ES; Carson JL; Panettieri RA; Blaser MJ
    J Mol Diagn; 2020 Jul; 22(7):871-875. PubMed ID: 32405270
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison analysis of different swabs and transport mediums suitable for SARS-CoV-2 testing following shortages.
    Garnett L; Bello A; Tran KN; Audet J; Leung A; Schiffman Z; Griffin BD; Tailor N; Kobasa D; Strong JE
    J Virol Methods; 2020 Nov; 285():113947. PubMed ID: 32781008
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rapid and Safe Detection of SARS-CoV-2 and Influenza Virus RNA Using Onsite Quantitative PCR Diagnostic Testing From Clinical Specimens Collected in Molecular Transport Medium.
    Daum LT; Fischer GW
    J Appl Lab Med; 2021 Nov; 6(6):1409-1416. PubMed ID: 34156459
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Copan eNAT Transport System To Address Challenges in COVID-19 Diagnostics in Regions with Limited Testing Access.
    Richard-Greenblatt M; Comar CE; Flevaud L; Berti M; Harris RM; Weiss SR; Glaser L
    J Clin Microbiol; 2021 Apr; 59(5):. PubMed ID: 33579730
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inactivation of SARS-CoV-2 virus in saliva using a guanidium based transport medium suitable for RT-PCR diagnostic assays.
    Banik S; Saibire K; Suryavanshi S; Johns G; Chakravorty S; Kwiatkowski R; Alland D; Banada PP
    PLoS One; 2021; 16(6):e0252687. PubMed ID: 34115762
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sample collection and transport strategies to enhance yield, accessibility, and biosafety of COVID-19 RT-PCR testing.
    Banada P; Elson D; Daivaa N; Park C; Desind S; Montalvan I; Kwiatkowski R; Chakravorty S; Alland D; Xie YL
    J Med Microbiol; 2021 Sep; 70(9):. PubMed ID: 34486972
    [No Abstract]   [Full Text] [Related]  

  • 9. Optimal preparation of SARS-CoV-2 viral transport medium for culture.
    McAuley J; Fraser C; Paraskeva E; Trajcevska E; Sait M; Wang N; Bert E; Purcell D; Strugnell R
    Virol J; 2021 Mar; 18(1):53. PubMed ID: 33691737
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Potential False-Negative Nucleic Acid Testing Results for Severe Acute Respiratory Syndrome Coronavirus 2 from Thermal Inactivation of Samples with Low Viral Loads.
    Pan Y; Long L; Zhang D; Yuan T; Cui S; Yang P; Wang Q; Ren S
    Clin Chem; 2020 Jun; 66(6):794-801. PubMed ID: 32246822
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of the SARS-CoV-2 Inactivation Efficacy Associated With Buffers From Three Kits Used on High-Throughput RNA Extraction Platforms.
    Thom RE; Eastaugh LS; O'Brien LM; Ulaeto DO; Findlay JS; Smither SJ; Phelps AL; Stapleton HL; Hamblin KA; Weller SA
    Front Cell Infect Microbiol; 2021; 11():716436. PubMed ID: 34604108
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analysis of Inactivation of SARS-CoV-2 by Specimen Transport Media, Nucleic Acid Extraction Reagents, Detergents, and Fixatives.
    Welch SR; Davies KA; Buczkowski H; Hettiarachchi N; Green N; Arnold U; Jones M; Hannah MJ; Evans R; Burton C; Burton JE; Guiver M; Cane PA; Woodford N; Bruce CB; Roberts ADG; Killip MJ
    J Clin Microbiol; 2020 Oct; 58(11):. PubMed ID: 32839250
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Cold Chain-Independent Specimen Collection and Transport Medium Improves Diagnostic Sensitivity and Minimizes Biosafety Challenges of COVID-19 Molecular Diagnosis.
    Saini V; Kalra P; Sharma M; Rai C; Saini V; Gautam K; Bhattacharya S; Mani S; Saini K; Kumar S
    Microbiol Spectr; 2021 Dec; 9(3):e0110821. PubMed ID: 34878310
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular Diagnosis of COVID-19: Challenges and Research Needs.
    Feng W; Newbigging AM; Le C; Pang B; Peng H; Cao Y; Wu J; Abbas G; Song J; Wang DB; Cui M; Tao J; Tyrrell DL; Zhang XE; Zhang H; Le XC
    Anal Chem; 2020 Aug; 92(15):10196-10209. PubMed ID: 32573207
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A comparison of health care worker-collected foam and polyester nasal swabs in convalescent COVID-19 patients.
    Hart B; Tu YP; Jennings R; Verma P; Padgett LR; Rains D; Vojta D; Berke EM
    PLoS One; 2020; 15(10):e0241100. PubMed ID: 33108384
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of Two Commercial Molecular Tests and a Laboratory-Developed Modification of the CDC 2019-nCoV Reverse Transcriptase PCR Assay for the Detection of SARS-CoV-2.
    Moore NM; Li H; Schejbal D; Lindsley J; Hayden MK
    J Clin Microbiol; 2020 Jul; 58(8):. PubMed ID: 32461287
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Performance of Abbott ID Now COVID-19 Rapid Nucleic Acid Amplification Test Using Nasopharyngeal Swabs Transported in Viral Transport Media and Dry Nasal Swabs in a New York City Academic Institution.
    Basu A; Zinger T; Inglima K; Woo KM; Atie O; Yurasits L; See B; Aguero-Rosenfeld ME
    J Clin Microbiol; 2020 Jul; 58(8):. PubMed ID: 32471894
    [TBL] [Abstract][Full Text] [Related]  

  • 18. SARS-CoV-2 detection using isothermal amplification and a rapid, inexpensive protocol for sample inactivation and purification.
    Rabe BA; Cepko C
    Proc Natl Acad Sci U S A; 2020 Sep; 117(39):24450-24458. PubMed ID: 32900935
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multi-center evaluation of cepheid xpert® xpress SARS-CoV-2 point-of-care test during the SARS-CoV-2 pandemic.
    Wolters F; van de Bovenkamp J; van den Bosch B; van den Brink S; Broeders M; Chung NH; Favié B; Goderski G; Kuijpers J; Overdevest I; Rahamat-Langedoen J; Wijsman L; Melchers WJ; Meijer A
    J Clin Virol; 2020 Jul; 128():104426. PubMed ID: 32417674
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of performance of two SARS-CoV-2 Rapid IgM-IgG combined antibody tests on capillary whole blood samples from the fingertip.
    Prazuck T; Colin M; Giachè S; Gubavu C; Seve A; Rzepecki V; Chevereau-Choquet M; Kiani C; Rodot V; Lionnet E; Courtellemont L; Guinard J; Pialoux G; Hocqueloux L
    PLoS One; 2020; 15(9):e0237694. PubMed ID: 32941461
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.